New Phase 3 trial: The Safety and Efficacy of HR19034 in Children With Myopia — Chengdu Suncadia Medicine Co., Ltd.
Why now
Thesis: Pediatric myopia trial results posted
Catalyst to watch: Regulatory filing by sponsor
Main risk: Results may not support approval
Why it matters
Completed myopia trial results inform a pediatric ophthalmology treatment's prospects.
Details
Sponsor: Chengdu Suncadia Medicine Co., Ltd.; Status: Completed; Conditions: Slowing the Progression of Myopia in Children; Interventions: HR19034, HR19034, Placebo; Enrollment: 509 (actual); First posted: 2026-09-28; NCT: NCT07844356
Related assets & topics
HealthcareSources
- clinicaltrials · 2026-09-28 12:00 UTC